BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25031191)

  • 1. Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review.
    Peinemann F; Labeit AM
    BMJ Open; 2014 Jul; 4(7):e005039. PubMed ID: 25031191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F; Bartel C; Grouven U
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.
    Peinemann F; Grouven U; Kröger N; Bartel C; Pittler MH; Lange S
    PLoS One; 2011 Apr; 6(4):e18572. PubMed ID: 21541024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
    Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
    Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
    Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
    Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
    Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe acquired aplastic anemia: historical outcome of patients treated by allogeneic bone marrow transplantation from matched sibling donors. A study by the Spanish Group for Bone Marrow Transplantation in Children (GETMON)].
    Muñoz Villa A; Díaz de Heredia C; Díaz González MA; Badell Serra I; Martínez Rubio A; González Valentín MA; Dasí Carpio MA; Gómez Pérez P; Bureo Dacal E; Olivé Oliveras T; Pérez Hurtado JM; Maldonado Regalado MS
    An Pediatr (Barc); 2008 Jul; 69(1):5-9. PubMed ID: 18620669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.
    Konopacki J; Porcher R; Robin M; Bieri S; Cayuela JM; Larghero J; Xhaard A; Andreoli AL; Dhedin N; Petropoulou A; Rodriguez-Otero P; Ribaud P; Moins-Teisserenc H; Carmagnat M; Toubert A; Chalandon Y; Socie G; Peffault de Latour R
    Haematologica; 2012 May; 97(5):710-6. PubMed ID: 22180425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of allogeneic haematopoietic stem cell transplantation in aplastic anaemia.
    Ahmed P; Chaudhry QU; Raza S; Mahmood SK; Satti TM; Anwar M; Altaf C; Shahbaz N; Satti HS
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):553-9. PubMed ID: 22980607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
    Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J
    Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
    Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
    [No Abstract]   [Full Text] [Related]  

  • 15. Single institution outcomes of treatment of severe aplastic anaemia.
    Mollee P; Woodward N; Durrant S; Lockwood L; Gillett EA; Morton J; Rowell J
    Intern Med J; 2001 Aug; 31(6):337-42. PubMed ID: 11529587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
    Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.
    Peinemann F; Grouven U; Kröger N; Pittler M; Zschorlich B; Lange S
    Haematologica; 2009 Dec; 94(12):1732-42. PubMed ID: 19648165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
    Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
    Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.
    Anderlini P; Wu J; Gersten I; Ewell M; Tolar J; Antin JH; Adams R; Arai S; Eames G; Horwitz ME; McCarty J; Nakamura R; Pulsipher MA; Rowley S; Leifer E; Carter SL; DiFronzo NL; Horowitz MM; Confer D; Deeg HJ; Eapen M
    Lancet Haematol; 2015 Sep; 2(9):e367-75. PubMed ID: 26685770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.